Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Amexdrug Corporation

Market Cap 19.45M 17.02M 15.73M 14.68M 27.53M 1.84B 27.79M 187M 72.66M 903M 73.01M 71.42M 3.14B P/E 2011
168x
P/E 2012 103x
Enterprise Value 20.23M 17.7M 16.36M 15.27M 28.63M 1.91B 28.9M 195M 75.57M 940M 75.93M 74.28M 3.27B EV / Sales 2011
1.38x
EV / Sales 2012 1.01x
Free-Float
8.4%
Yield 2011 *
-
Yield 2012 -
Current year 0
Extreme 0.0002
0
1 year 0
Extreme 0.0002
0
3 years 0
Extreme 0.0001
0
5 years 0
Extreme 0.0001
0.41
10 years 0
Extreme 0.0001
1.12
Manager TitleAgeSince
Chief Executive Officer 66 01/04/2000
General Counsel - -
Director TitleAgeSince
Chairman 66 01/04/2000
Director/Board Member 76 01/12/2001
Director/Board Member 72 01/12/2001
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%+100.00%-80.00% 33.82K
-0.77%-5.00%+3.32%+79.72% 87.88B
+0.44%-0.50%+36.32%+142.14% 51.94B
0.00%+4.55%-12.10%+222.81% 22.26B
+0.31%-2.33%-8.64%-22.86% 7.96B
+1.55%-1.13%-30.62%-31.78% 7.34B
-0.43%-4.06%-11.55%-32.04% 6.52B
+0.48%-4.53%+12.76%+18.46% 6.16B
+0.06%-0.82%-2.09%+18.00% 5.2B
-0.83%0.00%-4.77%-13.49% 3.56B
Average +0.08%-1.26%+8.26%+30.09% 19.88B
Weighted average by Cap. -0.17%-1.86%+8.00%+94.97%

Financials

2011 2012
Net sales 12.41M 10.86M 10.03M 9.36M 17.56M 1.17B 17.73M 119M 46.35M 576M 46.58M 45.56M 2B 9.15M 8.01M 7.4M 6.91M 12.95M 866M 13.07M 87.98M 34.18M 425M 34.35M 33.6M 1.48B
Net income 101K 88.08K 81.39K 75.97K 142K 9.53M 144K 968K 376K 4.68M 378K 370K 16.26M 82.03K 71.79K 66.34K 61.92K 116K 7.77M 117K 789K 307K 3.81M 308K 301K 13.25M
Net Debt 150K 131K 121K 113K 212K 14.2M 214K 1.44M 560K 6.97M 563K 551K 24.24M 778K 681K 629K 587K 1.1M 73.64M 1.11M 7.48M 2.91M 36.14M 2.92M 2.86M 126M
Logo Amexdrug Corporation
Amexdrug Corporation is a vertically integrated company, which is focused on healthcare and operating in the highly lucrative pharmaceutical, medical and cosmeceutical industry. The Company has eight business units, including Dermagen Inc., BioRx Pharma, BioRx Laboratories, Sponix Products, Royal Health Care, Amexhealth Plan and BioRx Labels. Dermagen Inc. manufactures pharmaceutical and skincare products, contract packaging and private labeling. BioRx Pharma unit is a manufacturer and distributor of pharmacy supplies, packaging and other health-care related products for pharmacy operations. BioRx Laboratories unit is a manufacturer and distributor of lab supplies and other related products for lab operations. BioRx Labels unit is a service provider of pharmacy labels. Sponix Products unit is health and wellness products for total health care. Royal Health Care develops and distributes nutraceuticals, nutritional supplements, vitamins and all-natural skincare products.
Employees
11
  1. Stock Market
  2. Stocks
  3. AXRX Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!